Response to Doxorubicin in Hairy Cell Leukaemia

Abstract
A case of hairy cell leukemia (HCL) treated by single-agent chemotherapy, after the failure of splenectomy, was reported. The patient was treated with doxorubicin 50 mg on 4 occasions over an 8 day period. After 2 wk of profound pancytopenia, substantial blood and bone marrow improvement ensued. This case demonstrates that HCL may in some cases be treated successfully by intensive chemotherapy.

This publication has 2 references indexed in Scilit: